SC
DGX icon

Seldon Capital’s Quest Diagnostics DGX Stock Holding History

Seldon Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-101
Closed -$15.8K – 101
2022
Q4 		$15.8K Hold
101
– – 0.01% 215
2022
Q3 		$12K Hold
101
– – 0.01% 242
2022
Q2 		$13K Hold
101
– – 0.01% 248
2022
Q1 		$14K Hold
101
– – 0.01% 255
2021
Q4 		$17K Buy
+101
New +$15.4K 0.01% 247

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Seldon Capital's DGX Position: Q1 2023 in Review

Seldon Capital sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 101 shares — an estimated $15.8K sold.

Seldon Capital first reported a position in DGX in Q4 2021 and held it in 5 quarters. The position peaked at $17K in Q4 2021. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

  • Seldon Capital reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Seldon Capital sold 101 Quest Diagnostics shares in Q1 2023, an estimated $15.8K.
  • Seldon Capital first reported a position in Quest Diagnostics in Q4 2021 and held it in 5 quarters.
  • Seldon Capital's Quest Diagnostics position peaked at $17K in Q4 2021.
  • 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Seldon Capital's 13F filing for Q1 2023, filed 12 May 2023.